132 related articles for article (PubMed ID: 15739160)
1. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
[TBL] [Abstract][Full Text] [Related]
2. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses.
Buzza MS; Hirst CE; Bird CH; Hosking P; McKendrick J; Bird PI
Cell Immunol; 2001 May; 210(1):21-9. PubMed ID: 11485349
[TBL] [Abstract][Full Text] [Related]
3. Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation.
Strik MC; de Koning PJ; Kleijmeer MJ; Bladergroen BA; Wolbink AM; Griffith JM; Wouters D; Fukuoka Y; Schwartz LB; Hack CE; van Ham SM; Kummer JA
Mol Immunol; 2007 Jul; 44(14):3462-72. PubMed ID: 17485116
[TBL] [Abstract][Full Text] [Related]
4. The granzyme B inhibitor, PI-9, is differentially expressed during placental development and up-regulated in hydatidiform moles.
Buzza MS; Hosking P; Bird PI
Placenta; 2006 Jan; 27(1):62-9. PubMed ID: 16310039
[TBL] [Abstract][Full Text] [Related]
5. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
[TBL] [Abstract][Full Text] [Related]
6. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.
Bladergroen BA; Strik MC; Bovenschen N; van Berkum O; Scheffer GL; Meijer CJ; Hack CE; Kummer JA
J Immunol; 2001 Mar; 166(5):3218-25. PubMed ID: 11207275
[TBL] [Abstract][Full Text] [Related]
7. Influence of pentoxifylline on natural cytotoxicity and expression of granzymes and PI-9, a specific granzyme B inhibitor.
Lazarczyk M; Dziunycz P; Niderla J; Milewski L; Lazarczyk MA; Boszczyk A; Samaha R; Grzela T
Int J Mol Med; 2006 Jan; 17(1):135-9. PubMed ID: 16328022
[TBL] [Abstract][Full Text] [Related]
8. The granzyme B inhibitor PI-9 is differentially expressed in all main subtypes of pediatric acute lymphoblastic leukemias.
Classen CF; Ushmorov A; Bird P; Debatin KM
Haematologica; 2004 Nov; 89(11):1314-21. PubMed ID: 15531453
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection.
Classen CF; Bird PI; Debatin KM
Clin Exp Immunol; 2006 Mar; 143(3):534-42. PubMed ID: 16487253
[TBL] [Abstract][Full Text] [Related]
10. Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A.
Dahlen JR; Foster DC; Kisiel W
Biochem Biophys Res Commun; 1997 Sep; 238(2):329-33. PubMed ID: 9299506
[TBL] [Abstract][Full Text] [Related]
11. Control of granzymes by serpins.
Kaiserman D; Bird PI
Cell Death Differ; 2010 Apr; 17(4):586-95. PubMed ID: 19893573
[TBL] [Abstract][Full Text] [Related]
12. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
Hirst CE; Buzza MS; Bird CH; Warren HS; Cameron PU; Zhang M; Ashton-Rickardt PG; Bird PI
J Immunol; 2003 Jan; 170(2):805-15. PubMed ID: 12517944
[TBL] [Abstract][Full Text] [Related]
13. Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers.
Strik MC; Wolbink A; Wouters D; Bladergroen BA; Verlaan AR; van Houdt IS; Hijlkema S; Hack CE; Kummer JA
Blood; 2004 Apr; 103(7):2710-7. PubMed ID: 14670919
[TBL] [Abstract][Full Text] [Related]
14. Detection of soluble human granzyme K in vitro and in vivo.
Bade B; Lohrmann J; ten Brinke A; Wolbink AM; Wolbink GJ; ten Berge IJ; Virchow JC; Luttmann W; Hack CE
Eur J Immunol; 2005 Oct; 35(10):2940-8. PubMed ID: 16208762
[TBL] [Abstract][Full Text] [Related]
15. Estrogen induction of the granzyme B inhibitor, proteinase inhibitor 9, protects cells against apoptosis mediated by cytotoxic T lymphocytes and natural killer cells.
Jiang X; Orr BA; Kranz DM; Shapiro DJ
Endocrinology; 2006 Mar; 147(3):1419-26. PubMed ID: 16306080
[TBL] [Abstract][Full Text] [Related]
16. Expression of the apoptosis inhibitor protease inhibitor 9 predicts clinical outcome in vaccinated patients with stage III and IV melanoma.
van Houdt IS; Oudejans JJ; van den Eertwegh AJ; Baars A; Vos W; Bladergroen BA; Rimoldi D; Muris JJ; Hooijberg E; Gundy CM; Meijer CJ; Kummer JA
Clin Cancer Res; 2005 Sep; 11(17):6400-7. PubMed ID: 16144945
[TBL] [Abstract][Full Text] [Related]
17. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells.
Mahrus S; Craik CS
Chem Biol; 2005 May; 12(5):567-77. PubMed ID: 15911377
[TBL] [Abstract][Full Text] [Related]
18. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes.
Sun J; Bird CH; Sutton V; McDonald L; Coughlin PB; De Jong TA; Trapani JA; Bird PI
J Biol Chem; 1996 Nov; 271(44):27802-9. PubMed ID: 8910377
[TBL] [Abstract][Full Text] [Related]
19. Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death.
Ida H; Nakashima T; Kedersha NL; Yamasaki S; Huang M; Izumi Y; Miyashita T; Origuchi T; Kawakami A; Migita K; Bird PI; Anderson P; Eguchi K
Eur J Immunol; 2003 Dec; 33(12):3284-92. PubMed ID: 14635036
[TBL] [Abstract][Full Text] [Related]
20. Proteinase inhibitor-9 expression is induced by maturation in dendritic cells via p38 MAP kinase.
Bots M; de Bruin E; Rademaker-Koot MT; Medema JP
Hum Immunol; 2007 Dec; 68(12):959-64. PubMed ID: 18191723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
